Literature DB >> 16772398

Risk factors of frequent exacerbations in difficult-to-treat asthma.

C Butler, L G Heaney.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16772398     DOI： 10.1183/09031936.06.00022606

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  The Saudi Initiative for Asthma - 2019 Update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Abdullah A Alangari; Mohammed O Al Ghobain; Mohammed O Zeitouni; Majdy M Idrees; Abdullah F Alanazi; Adel S Al-Harbi; Abdullah A Yousef; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2019 Jan-Mar       Impact factor: 2.219

2.  Therapeutic options for severe asthma.

Authors:  Jilcy Mathew; Wilbert S Aronow; Dipak Chandy
Journal:  Arch Med Sci       Date:  2012-09-08       Impact factor: 3.318

3.  Difficult-to-treat asthma, is it really difficult?

Authors:  Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2011-01       Impact factor: 2.219

4.  Factors leading to refractory asthma in patients from Saudi Arabia.

Authors:  Amal M Al-Moamary; Mohamed S Al-Hajjaj; Mohamed S Al Moamary
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

5.  The Saudi initiative for asthma - 2012 update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Mohamed S Al-Hajjaj; Mohammed O Al-Ghobain; Majdy M Idrees; Mohammed O Zeitouni; Adel S Al-Harbi; Maha M Al Dabbagh; Hussain Al-Matar; Hassan S Alorainy
Journal:  Ann Thorac Med       Date:  2012-10       Impact factor: 2.219

6.  The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.

Authors:  Mohamed S Al-Moamary; Sami A Alhaider; Majdy M Idrees; Mohammed O Al Ghobain; Mohammed O Zeitouni; Adel S Al-Harbi; Abdullah A Yousef; Hussain Al-Matar; Hassan S Alorainy; Mohamed S Al-Hajjaj
Journal:  Ann Thorac Med       Date:  2016 Jan-Mar       Impact factor: 2.219
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.